These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 1977180)
21. Differential effects of clorgyline on sensitization to quinpirole in rats tested in small and large environments. Dvorkin A; Culver KE; Szechtman H Psychopharmacology (Berl); 2006 Jul; 186(4):534-43. PubMed ID: 16758240 [TBL] [Abstract][Full Text] [Related]
22. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site. Gong W; Neill DB; Lynn M; Justice JB Neuroscience; 1999; 93(4):1349-58. PubMed ID: 10501459 [TBL] [Abstract][Full Text] [Related]
23. Constriction of environmental space and the behavioral response to the dopamine agonist quinpirole. Sullivan R; Dogaru C; Szechtman H Pharmacol Biochem Behav; 1992 Dec; 43(4):1217-9. PubMed ID: 1361993 [TBL] [Abstract][Full Text] [Related]
24. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Hu XT; White FJ Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772 [TBL] [Abstract][Full Text] [Related]
25. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens. Belcheva I; Bryer JB; Starkstein SE; Honig M; Moran TH; Robinson RG Brain Res; 1990 Nov; 533(2):286-91. PubMed ID: 1981170 [TBL] [Abstract][Full Text] [Related]
26. Hypophysectomy does not block sensitization to the dopamine agonist quinpirole or its modulation by the MAOI clorgyline. Culver KE; Szechtman H Horm Behav; 2004 Jan; 45(1):23-30. PubMed ID: 14733888 [TBL] [Abstract][Full Text] [Related]
27. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity. Johnson EF; Szechtman H Behav Pharmacol; 2016 Aug; 27(5):439-50. PubMed ID: 26871406 [TBL] [Abstract][Full Text] [Related]
28. Effects of ibotenic acid lesion of the medial prefrontal cortex on dopamine agonist-related behaviors in the rat. Braun AR; Jaskiw GE; Vladar K; Sexton RH; Kolachana BS; Weinberger DR Pharmacol Biochem Behav; 1993 Sep; 46(1):51-60. PubMed ID: 7902985 [TBL] [Abstract][Full Text] [Related]
29. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion. Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981 [TBL] [Abstract][Full Text] [Related]
30. D2-agonist quinpirole induces perseveration of routes and hyperactivity but no perseveration of movements. Eilam D; Golani I; Szechtman H Brain Res; 1989 Jun; 490(2):255-67. PubMed ID: 2527582 [TBL] [Abstract][Full Text] [Related]
31. Effects of intra-accumbens administration of dopamine agonists on stress-induced behavioural deficit. Płaźnik A; Stefański R; Puciłowski O; Kostowski W J Pharm Pharmacol; 1990 Feb; 42(2):79-84. PubMed ID: 1972406 [TBL] [Abstract][Full Text] [Related]
32. Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of rats. Einat H; Szechtman H Behav Brain Res; 1993 Mar; 54(1):35-41. PubMed ID: 8099289 [TBL] [Abstract][Full Text] [Related]
33. Bidirectional potentiation between D1 and D2 dopamine agonists: effects of unilateral intra-accumbens injections on locomotor activity in mice. Messier C; Mrabet O; Durkin TP; Destrade C Life Sci; 1991; 49(9):PL43-8. PubMed ID: 1678133 [TBL] [Abstract][Full Text] [Related]
34. Reevaluation of the two-component hypothesis for turning behaviour by manipulating activities in the striatum and the nucleus accumbens of intact rats. Saigusa T; Koshikawa N; Kitamura M; Kobayashi M Eur J Pharmacol; 1993 Jun; 237(2-3):161-8. PubMed ID: 8103458 [TBL] [Abstract][Full Text] [Related]
36. Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole. Einat H; Szechtman H Physiol Behav; 1995 Jan; 57(1):55-9. PubMed ID: 7878126 [TBL] [Abstract][Full Text] [Related]
37. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
38. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors. Subramaniam S; Lucki I; McGonigle P Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781 [TBL] [Abstract][Full Text] [Related]
39. Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole. Beerepoot P; Lam V; Luu A; Tsoi B; Siebert D; Szechtman H Neurosci Lett; 2008 Dec; 446(2-3):101-4. PubMed ID: 18824069 [TBL] [Abstract][Full Text] [Related]